Jubilant Pharmova
JUBLPHARMA.NS
#4037
Rank
C$3.23 B
Marketcap
$20.17
Share price
-1.31%
Change (1 day)
199.46%
Change (1 year)

Earnings for Jubilant Pharmova (JUBLPHARMA.NS)

Earnings in 2024 (TTM): C$0.11 Billion

According to Jubilant Pharmova's latest financial reports the company's current earnings are C$0.82 Billion. In 2023 the company made an earning of C$22.9 Million a decrease over its 2022 earnings that were of C$39.26 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jubilant Pharmova from 2012 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$0.11 B392.22%
2023 C$22.9 M-41.66%
2022 C$39.26 M-73.24%
2021 C$0.14 B-19.4%
2020 C$0.18 B19.42%
2019 C$0.15 B-35.23%
2018 C$0.23 B37.8%
2017 C$0.17 B27.68%
2016 C$0.13 B15.18%
2015 C$0.11 B330.67%
2014 C$26.96 M41.6%
2013 C$19.04 M-111.81%
2012 -C$0.17 Billion